|
|
Article: Nephros Raises $17M For Acute Renal Failure Device.
- Article from:
- BIOWORLD Today
- Article date:
- November 4, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Senior Staff Writer
Nephros Therapeutics Inc. raised $17 million in a Series C financing for its Renal Assist Device and, sounding like a sports team, attributed its success to excelling at the basics.
"It is a difficult financing environment," acknowledged Richard Andrews, CEO and president of Nephros, but he added: "It all comes back to fundamentals. The things that make the difference are quality clinical results, strong proprietary positions, creation of a team that can execute and a very tight focus on product development."
Lincoln, R.I.-based Nephros' lead product is its Renal Assist Device - a cellular replacement therapy system that ...